Guilford (GLFD) - Steadily Rising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tdinovo who wrote (95)	9/14/1997 7:12:00 PM
From: Czechsinthemail	of 496

Guilford is in an interesting cross-current. I think it has excellent long term potential, particularly with the additional financial strength the deal with Amgen offers. But in the near term, I think it is vulnerable to profit-taking. Company insiders, institutions and traders have made a lot on this company, and they may simply want to diversify or bank some profits. Though biotech company's often have big moves on news, it typically takes a long time for the news to play out as earnings. That disenchants investors with short time horizons, so they unload and move elsewhere. I think the likelihood of the stock declining some on profit-taking is pretty good. For long term investors, buying on any pullbacks should be a great opportunity. Baird

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next